StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
AMPHAmphastar Pharmaceuticals, Inc.
stockpulse.co.kr
Nasdaq
$24.90▼ 0.92%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $1.10BShares out 44.1M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

12
  • 9.23After-hours26.09.24 07:02
    4Ownership#●●●

    Amphastar Pharmaceuticals, Inc.

    William J. Peters, an executive at Amphastar Pharmaceuticals, reported an insider transaction of company shares dated September 21, 2026. This filing serves as an official disclosure of the insider's change in beneficial ownership via Form 4.…more

    $24.90-0.92%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 9.21After-hours26.09.22 07:37
    144Ownership

    Amphastar Pharmaceuticals, Inc.

    William J. Peters, an executive at Amphastar Pharmaceuticals, has filed an SEC Form 144 to report a proposed sale of company shares. This filing serves as a standard notification of an insider's plan to dispose of their holdings.…more

    $24.90-0.92%vs prev close
    View filingShare
  • 9.17After-hours26.09.18 07:19
    4Ownership

    Amphastar Pharmaceuticals, Inc.

    Insider Zhou Rong of Amphastar Pharmaceuticals reported a change in beneficial ownership of securities as of September 16, 2026. This filing serves as a standard disclosure of insider equity transactions and does not contain any material financial or operational updates.…more

    $24.90-0.92%vs prev close
    View filingShare

11 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire

No news collected yet. New articles will appear here.